While MDS shares some genetic features with CHIP, such as mutations in epigenetic regulators, it also exhibits cytogenetic aberrations and additional mutations, especially in RNA splicing factors (SF3B1, SRSF2, ZRSR2)15,16. This evidence concerns the gene SF3B1 and myelodysplastic syndrome.